RE:4050 still on hold because they say we need to analyse pk daDoing nothing is a delay tactic that favours Thomvest as majority shareholder and SALP affiliate who owns the debt. This scenario is a benefit also in the lawsuit suggesting that there is no value left in this company so they were fooled by previous management. too. They have stopped any communication and even stopped quarterly conference calls. Alstrom, IPF and Metabolic Syndrome results apparently did not make the grade or that's what they would like investors to believe while they take possession of the entire company. That's one theory.
edrose wrote: Data before we proceed to next step it doesn't take that much time to analyse data on FEW patients
it will interesting when they question scientists under oath
There's a reason why they are delaying what do people think